TASMULINE DFZ : Available Online at Upto 30% OFF

TASMULINE DFZ

Tamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg

Tamsulosin Hydrochloride 0.4 mg PR (prolonged-release) and Deflazacort 30 mg, commonly known as TASMULINE DFZ, is a pharmaceutical formulation that combines two active ingredients to address specific medical conditions. This combination medication is primarily used to treat benign prostatic hyperplasia (BPH), a condition characterized by the enlargement of the prostate gland in men, and various inflammatory and autoimmune conditions.

Composition:

TASMULINE DFZ combines two active ingredients:

1. Tamsulosin Hydrochloride: Tamsulosin is an alpha-blocker that works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. By alleviating symptoms associated with BPH, such as urinary hesitancy, urgency, and frequency, tamsulosin improves the quality of life for individuals suffering from this condition.
2. Deflazacort: Deflazacort is a corticosteroid with anti-inflammatory and immunosuppressive properties. It is used to treat a variety of inflammatory and autoimmune conditions, including asthma, rheumatoid arthritis, lupus, and certain skin disorders. Deflazacort helps reduce inflammation and suppress the immune response, thereby alleviating symptoms associated with these conditions.

Uses:

TASMULINE DFZ is prescribed for the following conditions:

1. Benign Prostatic Hyperplasia (BPH): TASMULINE DFZ helps relieve symptoms associated with BPH, such as difficulty urinating, weak urine flow, frequent urination, and the urge to urinate during the night. By relaxing the muscles in the prostate and bladder neck, tamsulosin facilitates the passage of urine and improves urinary symptoms.
2. Inflammatory and Autoimmune Conditions: Deflazacort in TASMULINE DFZ is effective in managing various inflammatory and autoimmune conditions, including asthma, rheumatoid arthritis, lupus, dermatitis, and allergic reactions. It works by suppressing the immune response and reducing inflammation, thereby alleviating symptoms such as pain, swelling, redness, and allergic reactions.

Dosage:

The dosage of TASMULINE DFZ may vary depending on the individual's medical condition, age, and response to treatment. It is essential to follow the prescribing physician's instructions and adhere to the recommended dosage regimen. Generally, the typical dosage of TASMULINE DFZ for BPH is one capsule daily, preferably taken after a meal. For inflammatory and autoimmune conditions, the dosage may vary, and the treatment duration will be determined by the severity of the condition and the individual's response to therapy. It is crucial not to exceed the prescribed dosage without consulting a healthcare professional.

Price:

The price of TASMULINE DFZ may vary depending on factors such as the brand, dosage strength, quantity, and location. It is available in various generic and brand-name formulations, with prices ranging from affordable to moderately expensive. Patients are advised to compare prices at different pharmacies or online retailers to find the best deals and discounts. Additionally, some healthcare providers may offer patient assistance programs or discounts to eligible individuals, helping make the medication more affordable.

Side Effects:

While TASMULINE DFZ is generally well-tolerated, it may cause certain side effects in some individuals. Common side effects associated with tamsulosin include dizziness, headache, drowsiness, dizziness upon standing (orthostatic hypotension), retrograde ejaculation (semen flowing backward into the bladder), and nasal congestion. On the other hand, common side effects of deflazacort may include weight gain, increased appetite, fluid retention, mood changes, insomnia, and gastrointestinal disturbances (such as indigestion, nausea, and abdominal pain). It is essential to inform the prescribing physician if any side effects persist or worsen over time.

In rare cases, TASMULINE DFZ may cause more severe side effects, such as allergic reactions, liver problems, eye problems (such as cataracts or glaucoma), and adrenal suppression (especially with long-term use of corticosteroids like deflazacort). Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, chest pain, swelling of the face or throat, severe dizziness, vision changes, persistent abdominal pain, dark urine, or unusual fatigue. Additionally, it is crucial to inform healthcare providers of any pre-existing medical conditions, allergies, or medications to avoid potential drug interactions or complications.

Precautions:

Before taking TASMULINE DFZ, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are taking, including prescription drugs, over-the-counter medications, and herbal supplements. Certain medical conditions or medications may interact with TASMULINE DFZ, affecting its efficacy or increasing the risk of side effects. Patients with a history of prostate cancer, kidney or liver disease, low blood pressure, or eye problems should use TASMULINE DFZ with caution and under close medical supervision.

Pregnant or breastfeeding women should avoid using TASMULINE DFZ unless prescribed by a healthcare professional, as the safety of this medication during pregnancy or lactation has not been established.

Conclusion:

TASMULINE DFZ, combining tamsulosin hydrochloride and deflazacort, is a valuable pharmaceutical formulation used to treat benign prostatic hyperplasia (BPH) and various inflammatory and autoimmune conditions. By addressing urinary symptoms associated with BPH and alleviating inflammation and immune-mediated responses, TASMULINE DFZ improves the quality of life for individuals suffering from these conditions. However, like all medications, TASMULINE DFZ may cause side effects and interactions in some individuals, necessitating close medical supervision and monitoring. Patients should follow the prescribed dosage regimen, inform healthcare providers of any pre-existing medical conditions or medications, and seek immediate medical attention if they experience any concerning symptoms. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. Gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW